Diaryltriazoles as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1

Details for Australian Patent Application No. 2005230864 (hide)

Owner Merck and Co., Inc.

Inventors Balkovec, James M.; Gu, Xin; Graham, Donald W.; Kevin, Nancy J.; Aster, Susan D.; Ponpipom, Mitree; Patel, Gool F.

Agent Spruson & Ferguson

Pub. Number AU-A-2005230864

PCT Pub. Number WO2005/097759

Priority 60/557,344 29.03.04 US

Filing date 25 March 2005

Wipo publication date 20 October 2005

International Classifications

C07D 249/08 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

Event Publications

19 October 2006 PCT application entered the National Phase

  PCT publication WO2005/097759 Priority application(s): WO2005/097759

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

20 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005230867-Certain triazole-based compounds, compositions, and uses thereof

2005230862-An improved process for the preparation of N- ((1,2,4)triazolopyrimidin-2-yl)aryl sulfonamides